Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 52(4): e8006, 2019. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1001515

Résumé

The aim of the study was to evaluate the diagnostic accuracy of thromboelastometry for assessing rivaroxaban concentrations. The accuracy of thromboelastometry was compared with the high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method, which is the gold standard for drug plasma monitoring (the reference standard). Forty-six clinically stable patients were treated with 10, 15, or 20 mg of rivaroxaban once daily (OD group) or 15 mg twice a day (BID group) (no particular indication for treatment). Patient samples were collected 2 h after the use of the medication (peak) and 2 h before the next dose (trough). The rivaroxaban plasma concentrations were determined via HPLC-MS/MS, and thromboelastometry was performed using a ROTEM® delta analyzer. There were significant prolongations in clotting time (CT) for the 10, 15, and 20 mg of rivaroxaban treatments in the OD groups. In the 15 mg BID group, the responses at the peak and trough times were similar. At the peak times, there was a positive correlation between the plasma concentration of rivaroxaban and CT (Spearman correlation rho=0.788, P<0.001) and clot formation time (rho=0.784, P<0.001), and a negative correlation for alpha angle (rho=−0.771, P<0.001), amplitude after 5 min (rho=−0.763, P<0.001), and amplitude after 10 min (rho=−0.680, P<0.001). The CT presented higher specificity and sensitivity using the cut-off determined by the receiver characteristics curve. ROTEM has potential as screening tool to measure possible bleeding risk associated with rivaroxaban plasma levels.


Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Surveillance des médicaments/méthodes , Inhibiteurs du facteur Xa/sang , Rivaroxaban/sang , Hémorragie/prévention et contrôle , Thromboélastographie , Tests de coagulation sanguine , Chromatographie en phase liquide à haute performance , Spectrométrie de masse en tandem , Inhibiteurs du facteur Xa/administration et posologie , Rivaroxaban/administration et posologie , Exactitude des données
2.
Rev. bras. ginecol. obstet ; 5(2): 55-61, 1983.
Article Dans Portugais | LILACS | ID: lil-14412

Résumé

A comparacao dos dados clinicos com os quadros flebograficos e laparoscopicos deixou a impressao de que pode haver alteracao de retorno na pelve, traduzida por um esvaziamento lento do contraste de rede venosa visceral, sem que haja ainda aspecto de varizes pelvicas, enquanto, ao contrario, nao verificamos casos com varizes evidentes a flebografia e/ou laparoscopia com tempos de esvaziamento normais. Ja em relacao a correspondencia entre os dados objetivos fornecidos pelos dois metodos de exame e a clinica de dor pelvica cronica, esta correlacao deixa muito a desejar.Comparando os resultados dos dois metodos, a taxa e de positividade foi de 85% para a laparoscopia e de 70% para a flebografia.E importante salientar que, em cinco casos em que a flebografia foi normal, a laparoscopia mostrou sinais de congestao e/ou varizes nas veias viscerais da pelve. Parece-nos, assim, que a laparoscopia apresenta sobre a flebografia pelvica por via endouterina, em nossa experiencia inicial, claras vantagens como metodo de investigacao para o estudo da circulacao de retorno na pelve


Sujets)
Humains , Laparoscopie , Pelvis , Phlébographie
SÉLECTION CITATIONS
Détails de la recherche